New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study

20260 citationsJournal Articlehybrid Open Access

Authors

German Research Foundation, Prostate Cancer Foundation, Innovative Health Initiative Joint Undertaking, Novartis, AstraZeneca, and Amgen.

Good health and well-being

Published in: The Lancet Oncology

Volume 27, Issue 4, pp. 480-490

Field-Weighted Citation Impact: 0.00